Prone positioning for non-intubated spontaneously breathing patients with acute hypoxaemic respiratory failure: a systematic review and meta-analysis.

BACKGROUND: Prone positioning in non-intubated spontaneously breathing patients is becoming widely applied in practice alongside noninvasive respiratory support. This systematic review and meta-analysis evaluates the effect, timing, and populations that might benefit from awake proning regarding oxygenation, mortality, and tracheal intubation compared with supine position in hypoxaemic acute respiratory failure.
METHODS: We conducted a systematic literature search of PubMed/MEDLINE, Cochrane Library, Embase, CINAHL, and BMJ Best Practice until August 2021 (International Prospective Register of Systematic Reviews [PROSPERO] registration: CRD42021250322). Studies included comprise least-wise 20 adult patients with hypoxaemic respiratory failure secondary to acute respiratory distress syndrome or coronavirus disease (COVID-19). Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed, and study quality was assessed using the Newcastle-Ottawa Scale and the Cochrane risk-of-bias tool.
RESULTS: Fourteen studies fulfilled the selection criteria and 2352 patients were included; of those patients, 99% (n=2332/2352) had COVID-19. Amongst 1041 (44%) patients who were placed in the prone position, 1021 were SARS-CoV-2 positive. The meta-analysis revealed significant improvement in the PaO2/FiO2 ratio (mean difference -23.10; 95% confidence interval [CI]: -34.80 to 11.39; P=0.0001; I2=26%) after prone positioning. In patients with COVID-19, lower mortality was found in the group placed in the prone position (150/771 prone vs 391/1457 supine; odds ratio [OR] 0.51; 95% CI: 0.32-0.80; P=0.003; I2=48%), but the tracheal intubation rate was unchanged (284/824 prone vs 616/1271 supine; OR 0.72; 95% CI: 0.43-1.22; P=0.220; I2=75%). Overall proning was tolerated for a median of 4 h (inter-quartile range: 2-16).
CONCLUSIONS: Prone positioning can improve oxygenation amongst non-intubated patients with acute hypoxaemic respiratory failure when applied for at least 4 h over repeated daily episodes. Awake proning appears safe, but the effect on tracheal intubation rate and survival remains uncertain. Crown

Prone positioning in non-intubated, spontaneously breathing patients is widely applied alongside noninvasive respiratory support. Its effectiveness in improving oxygenation and reducing intubation rate and mortality, and its tolerability, timing, and optimal duration are unclear.

Awake prone positioning appears to be a safe and tolerable intervention for non-intubated patients with hypoxaemic respiratory failure attributable to acute respiratory distress syndrome or COVID-19.

Potential benefits include improved oxygenation and mortality rate, but no significant effects on incidence of intubation or critical care admission were found.

Future research should explore the optimal frequency, duration, and appropriate population for application of awake prone positioning with noninvasive respiratory support. Large, well-designed trials are needed to explore the subject more rigorously and to confirm clinical effectiveness.

Prone positioning is an established evidence-based practice for mechanically ventilated patients with moderate-to-severe acute respiratory distress syndrome (ARDS), but it is a novel intervention in spontaneously breathing patients. Physiologically, prone positioning may promote lung recruitment of the posterior dorsal regions because of reversal of atelectasis. Proning may also generate a more homogeneous ventilation reducing lung strain attributable to changes in pleural pressure and pleural space distribution, and therefore favouring ventilation/perfusion (V/Q) matching and reducing shunting.

Awake prone positioning in hypoxaemic acute respiratory failure (ARF) can be a feasible and safe intervention , alongside noninvasive ventilation (NIV) and high-flow oxygen. Despite its anecdotal and theoretical benefit in improving oxygenation, it has not been widely applied in practice until the SARS-CoV-2 pandemic. The unprecedented surge of patients requiring critical care support generated significant pressure on ICU capacity. Clinicians needed to balance local resources with the rapid demand, and awake prone positioning was initially a pragmatic approach with the goal to improve oxygenation, prevent intubation, and potentially reduce the need for ICU admission. ,

The natural progression and the pathophysiological changes of ARDS and COVID-19 respiratory failure affect critically ill patients with different degrees of severity, and 42–58% will require intubation and invasive mechanical ventilation. , Invasive mechanical ventilation may lead to additional risks, such as ventilation-associated pneumonia and ventilation-induced lung injury, and its associated mortality rate may reach 27–45%. ,

Several observational studies support the use of awake prone positioning to improve oxygenation for spontaneously breathing patients affected by respiratory failure.13, 14, 15, 16, 17, 18 Its effectiveness in reducing intubation rate and mortality remains unclear,19, 20, 21, 22, 23 and also its tolerability, , timing, and optimal duration. A general potential concern is that APP may worsen self-inflicted lung injury and delay intubation and mechanical ventilation. , It remains unclear if there is a specific window for awake prone positioning to improve oxygenation (in terms of both time and levels of hypoxia), or if there exist subgroups of responders and non-responders.

This review and meta-analysis aims to further evaluate the hypothesis that awake prone positioning in spontaneously breathing patients with ARF is associated with improvement in oxygenation and rate of tracheal intubation and mortality. We also investigated potential risks and limitations associated with awake prone positioning. This work will inform future studies and allow evaluation of potentially effective interventions for improving the management of spontaneously breathing patients with ARF.

Methods

This study was registered on the International Prospective Register of Systematic Reviews (PROSPERO) of the National Institute for Health Research (NIHR), and it is published under registration ID CRD42021250322.

Search strategy

Two reviewers (BF and AP) independently identified all potentially relevant studies published from January 2010 to August 2021. The search strategy involved a combination of keywords as follows: (i) awake prone positioning, (ii) acute respiratory distress or ARDS or hypoxaemic respiratory failure, or (iii) coronavirus 2019 or COVID-19 or SARS-CoV-2. The search ran through electronic databases, including PubMed/MEDLINE, Cochrane Central Register of Controlled Trials, Embase, CINAHL, BMJ Best Practice, WHO SARS-CoV-2 Research Database, National Institute for Health and Care Excellence (NICE), and Cambridge University Press Coronavirus Free Access Collection. The references were identified against our inclusion criteria and duplicates removed, as shown in Figure 1 . There were no language restrictions. Titles and abstracts were reviewed independently in duplicate (BF and AP) for selection of full-text review. Both reviewers also independently reviewed the full text of relevant studies and decided on eligibility. Disagreements were resolved through discussion or by consensus with a third reviewer (ZP). The references retrieved were saved into a customised Excel (Microsoft 365®, Microsoft Corp., Redmond, WA, USA) spreadsheet. This report follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines.

Fig 1

Search strategy flow diagram.

Study inclusion criteria

We selected all design studies, including at least 20 participants. Studies were not selected on methodological quality. Eligible studies included adult patients (age ≥18 yr old) with acute hypoxaemic respiratory failure attributable to ARDS or COVID-19 who received PP alongside with any oxygen delivery device, including simple oxygen therapy, high-flow nasal oxygen, CPAP, and NIV. We included patients of any gender admitted to any ward or to ICU.

We excluded studies (i) that applied prone position in intubated patients, (ii) that involved the application of prone positioning combined or mixed to lateral positioning, and (iii) with a follow-up shorter than 7 days.

Data extraction and study quality

Data extraction was undertaken independently and in duplicate (BF and AP) to avoid bias. Data abstracted were stored into a customised Excel database, including study design, patient characteristics, intervention, and outcomes.

Observational studies were assessed for evidence of bias using the Newcastle–Ottawa Scale (NOS), and RCTs were assessed with the Cochrane risk-of-bias tool. The GRADE (Grading of Recommendations Assessment), Development and Evaluation guidelines were used for rating the quality of evidence.

Outcomes

We analysed the following outcomes based on consensus. The primary outcome considered was the change in oxygenation pre and post PP reported as Pa/FiO2 (P/F) ratio or SpO2/FiO2 (S/F) ratio. The secondary outcomes included the rate of tracheal intubation, mortality, ICU admission, limitations, and adverse events (such as line displacement and pressure sores).

Subgroup analysis

A subgroup analysis was planned based on P/F ratio (P/F ratio <150 mm Hg vs P/F ratio >150 mm Hg) and length of prone positioning (PP <4 h vs PP >4 h).

Study analysis

Where P/F ratio was not available, S/F ratio was transformed into P/F ratio following the validated standard formula.

We reported dichotomous outcomes using risk ratio and continuous outcomes using mean difference (MD). If mean and standard deviation were not available, data were assessed in the median/inter-quartile range (IQR) and transformed into standard MD format for further comparison. The inverse variance method was used to pool the MDs to yield an overall effect size with 95% confidence intervals (CIs).

For each analysis, studies were weighted using the inverse variance method, and data were pooled using a random effects meta-analyses model accounting for the incidence. We assessed clinical heterogeneity amongst studies qualitatively, and statistical heterogeneity using the χ test and I statistical measure. , P-value equal to 0.05 or less was considered to be statistically significant. We assessed publication bias by visually examining funnel plots of treatment effect vs study precision. All statistical data analyses were performed using the statistical software package Review Manager 5.4 (RevMan 5.4.1) from Cochrane Collaboration (Oxford, UK).

Results

A total of 417 studies were identified by the search strategy, and after removal of duplicates 14 studies met the inclusion criteria, as shown in Figure 1. The study characteristics are summarised in Table 1 . All studies were recent and published between 2020 and 2021, comprising patients with moderate-to-severe respiratory failure secondary to ARDS or COVID-19. In all, 2352 patients were included, of those 99% (n=2332/2352) had COVID-19. Amongst 1041 (44%) undergoing awake prone positioning, 1021 were SARS-CoV-2 positive.

Table 1

Baseline characteristics of included studies. APP, awake prone positioning; ARDS, acute respiratory distress syndrome; BNP, brain natriuretic peptide; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ED, emergency department; HFNO, high-flow nasal oxygen; IQR, inter-quartile range; NC, nasal cannula; NIV, noninvasive ventilation; NRM, non-rebreathing mask; NYHA, New York Heart Association; PC, prospective cohort; P/F, Pa/FiO2 ratio; PP, prone position; RC, retrospective cohort; RR, risk ratio; sd, standard deviation.

Authors	Design and country	N	Inclusion criteria	Exclusion criteria	Setting	Oxygen delivery mode	Protocol	Duration of APP session	Follow-up	Oxygenation pre- vs post-APP	Intubation rate, n (%)	Mortality, n (%)	Limitations
Coppo and colleagues13 (2020)	PCItalySingle centre	5647 prone9 supine	SARS-CoV-2 and hypoxaemia	Not collaborative, altered mental status, NYHA <II, increased BNP, COPD on home,NIV or O2, impending intubation	EDWard ICU	Helmet, CPAP, reservoir mask,Venturi mask	Assisted prone position encouraged for 3 h, to repeat up to 8 h day−1	Median 3 h (3–4) up to seven sessions	Hospital discharge	P/F ratio: 163 mm Hg (sd 57) in supine position vs P/F ratio 179 mm Hg (sd 84) 1 h after resupination; P=0.290	18/47 (38%) for prone5/9 (56%) for supine	5/56 (9%)	9% discomfort4% worsening oxygenation2% coughing
Ding and colleagues7 (2020)	PCChinaMulticentre	20 prone	ARDS (viral pneumonia)P/F <200 and on NIV	Requiring intubation	ICU	HFNO and NIV	>30 min, twice daily for 3 days	2.4 [1.5] h for those not intubated1.6 [0.5] h for those intubated	Not reported	Not reported	9/20 (45%)	1/20 (5%)	10% intolerance
Dubosh and colleagues16 (2021)	PCUSASingle centre	22 prone	SARS-CoV-2Hypoxaemia	Requiring intubation, altered conscious level, spinal instability, vomiting, confusion, inability to cooperate with staying in a prone position	ED	NC, face mask	As tolerated	Median: 2 h (IQR 1–3)	Hospital discharge	Not reported	7/22 (32%)	2/22 (9%)	9/22 (41%) ICU admission
Elharrar and colleagues9 (2020)	PCFranceSingle centre	24 prone	SARS-CoV-2Hypoxaemia	Requiring intubation, altered consciousness	Ward	NC, face mask, HFNO	A single episode with no goal duration	17% <1 h21%: 1–3 h63% >3 h	10 days	No difference; P=0.530	5/24 (20.8%)	Not reported	10/24 (42%) back pain
Ferrando and colleagues20 (2020)	PCSpainMulticentre	19955 prone144 supine	SARS-CoV-2Hypoxaemia	Not reported	ICU	HFNO	Prone position was only considered if the duration was >16 h day−1 regardless of the number of sessions	Unclear	28 days	Not reported	22/55 (40%) for prone60/144 (42%) for supine	(RR 1.04 [95% CI: 0.40–2.72]; P=0.92)	Trend in delay intubation
Padrao and colleagues 51 (2020)	RCBrazilSingle centre	16657 prone109 supine	SARS-CoV-2Hypoxaemia	Need for intubation, haemodynamic instability, recent abdominal surgery, acute hypercapnic respiratory failure, unstable fractures, pregnancy, clinician judgement	ED Ward ICU	NC, face mask, HFNO, NIV	As tolerated	Unclear29/57 (58%) >4 h	15 days	Spo2/Fio2 ratio: 196 mm Hg [128, 254] supine vs 224 mm Hg [159, 307] 4 h after APP; P<0.001	APP: 33/57 (58%)Control: 53/109 (49%)P=0.39	6/57 (11%) for prone22/109 (20%) for supineP=0.26	3.5% accidental removal of peripheral lines
Thompson and colleagues15 (2020)	PCUSASingle centre	2925 prone4 refused	SARS-CoV-2Hypoxaemia	Altered mental status, inability to turn without help, immediate intubation needed, mild hypoxaemia	HDU	NC, NRM	As tolerated over repeated episodes daily	4 h (IQR: 1–24) in not intubated6 h (IQR: 1–24) in intubated	Up to 49 days or to hospital discharge	Not reported	12/25 (48%)	3/25 (12%)	4/29 (14%) refusal
Zang and colleagues18 (2020)	PCChinaSingle centre	6023 prone37 supine	SARS-CoV-2Hypoxaemia	Need for intubation, instability to self-position, basal lung disease, unstable spine, high ICP, severe burns, abdominal surgery, abdominal hypertension, cranial injury, tracheostomy, immune suppression, pregnant, imminent death	ICU	NC, HFNO, NIV	Evaluation of muscle strength and self-positioningEncouraged for 1–2 h per session for three to four times day−1 for 5 days	9 h (IQR: 8–22)	90 days	Not reported	APP: 8/23 (35%)Supine: 3/37 (8%)	10/23 (43%) for prone28/37 (76%) for supine	Not reported
Ehrmann and colleagues 52 (2021)	RCTMexicoFranceUSASpainIrelandCanada	564 prone557 supine	SARS-CoV-2Hypoxaemia	Unable or refused to provide informed consent, haemodynamic instability, severely obese with BMI >40 kg m−2, pregnant, had a contraindication to awake prone positioning	ICU,HDUEDWard	HFNO	As long and as frequently as possible each day	5 h (IQR: 1.6–8.8)	28 days	Spo2/Fio2 ratio significantly improved; P-value not reported	APP: 185/564 (33%)Supine: 223/557 (40%)RR: 0.75 (0.62–0.91)	APP: 117/564 (21%)Supine: 132/557 (24%)RR: 0.87 (0.71–1.07)	Incidence of skin breakdown, vomiting, and dislodged line was low and similar in both groups
Fazzini and colleagues14 (2021)	PCUKSingle centre	46 prone	SARS-CoV-2Hypoxaemia	Need for intubation, haemodynamic instability, recent abdominal surgery, acute hypercapnic respiratory failure, facial fractures, spinal instability, unstable fractures, TBI, pregnancy, not collaborative, clinician judgement	Ward	NC, face mask, HFNO, CPAP	Assisted prone positionEncouraged as long as tolerated multiple daily sessions	4 h (IQR: 1–14)	90 days	P/F ratio: 115 [43] mm Hg pre-PP vs 148 [70] mm Hg 1–2 h post-PP; P=0.025Spo2/Fio2 ratio: 141 [37] mm Hg supine vs 188 [49] mm Hg 1–2 h post-PP; P<0.001	20/46 (43%)	14/46 (30%)	13% anxiety11% discomfortICU admission: (APP <1 h: 83%, 10/12 vs APP >1 h: 41%, 14/34; P=0.011)
Jouffroy and colleagues (2021)	RCFranceMulticentre	37940 prone339 supine	SARS-CoV-2Hypoxaemia	Not reported	ICU	Face mask, HFNO, CPAP	3 h and twice daily when possible	2.5 days (1.6–3.4) daysTotal of three sessions	28 days	P/F (78 [68; 96] vs 63 [53; 77] mm Hg; P=0.004)	16/44 (40%)HR 0.96; 95% CI: 0.49–1.88	23/40 (58%)HR 0.51; 95% CI: 0.16–1.16	Not reported
Nauka and colleagues22 (2021)	RCUSAMulticentre	41 prone	SARS-CoV-2Hypoxaemia	Not reported	WardICU	NC, NRM, HFNO	Not reported	Unclear	Hospital discharge	Spo2/Fio2 ratio: 95 mm Hg (93–133) pre vs 95 mm Hg (92–100) post; P=0.800	20/41 (49%)	Not reported	Not reported
Rosén and colleagues46 (2021)	RCTSwedenMultiCentre	7539 control36 treatment	SARS-CoV-2Hypoxaemia	Inability to assume PP or semi-prone, immediate need for tracheal intubation, severe haemodynamic instability, previous intubation for COVID-19, pregnancy, terminal illness with less than 1 yr life expectancy, do-not-intubate order, inability to understand oral or written study information	Ward ICU	HFNO or NIV	Control group: APP was not encouraged but prescribed at clinician discretionTreatment group: at least 16 h day−1Prone or semi prone position allowedStopped if need for intubation, death, or clinically improved	Control: 3.4 h (IQR: 1.8–8.4)Treatment: 9.0 h (IQR: 4.4–10.6)	30 days	Not reported	Control: 13/39 (33%)Treatment: 12/36 (33%)HR: 1.01 (CI: 0.46–2.21); P=0.99	Control: 3/39 (8%)Treatment: 6/36 (17%)HR: 2.29 (CI: 0.57–9.14); P=0.30	Control: 9/39 (23%) pressure sores in lower back and gluteal region1/39 (2.6%) cardiac arrestTreatment: 2/36 (6%) pressure sore from HFNO2/36 (6%) cardiac arrestICU admission: P=0.580
Tonelli and colleagues17 (2021)	RCItalyMultiCentre	11438 prone76 supine	SARS-CoV-2Hypoxaemia	Not collaborative, altered mental status, NYHA <II, increased BNP, COPD on home, NIV or O2, impending intubation	ICU	HFNO, CPAP, NIV	Assisted prone positionEncouraged as long as tolerated aiming for 3 h for one to four sessions a day	Unclear	30 days	Not reported	7/38 (18%) for prone30/76 (39%) for supine	5/38 (13%) for prone17/76 (23%) for supine	ICU admission: (HR 1.14 [0.96, 1.34]; P=0.183)

There were five multicentre and six single-centre studies, and one multicentre RCT across Asia, Europe, and North and South America. The NOS found relatively high risk of bias with five studies of good quality, one study of fair quality, and six studies of poor quality (refer to the Supplementary table). The Cochrane risk-of-bias tool reported potential for unclear and high risk of bias with particular loss of precision regarding the blinding of personnel, as seen in the Supplementary materials.

Primary outcome

The MD in Pa/FiO2 ratio before and after APP was –23.10 (–34.80 to –11.39; P<0.0001; I 2=26%) using outcomes from the five studies that reported this information (see Fig. 2 ). A subgroup analysis was performed for proning duration of >4 or <4 h. There was a difference in Pa/FiO 2 ratio of –16.91 (–25.25 to –8.31; P<0.0001; l 2=0%) in those placed in prone position <4 h compared with a larger improvement in Pa/FiO2 ratio of –37.47 (–56.70 to –18.23; P<0.0001; l 2=0%) in those placed in the prone position >4 h. Considering, however, the limited number of studies per subgroup with 87 and 102 patients each, respectively, we were unable to draw substantial conclusions from this analysis.

Fig 2

Primary outcome: changes in oxygenation. Forest plot demonstrating pooled data of changes in Pa/FiO2 ratio pre- and post-awake prone positioning using a random effects model. CI, confidence interval; PP, prone position; sd, standard deviation.

Despite all patients included the fitting criteria for moderate-to-severe ARDS (Pa/FiO2 <200 mm Hg), we were unable to evaluate the specific Pa/FiO2 threshold at which one might benefit most from awake proning, and this remains unclear.

Secondary outcomes

We only included studies with a control group, including patients in supine position only, as qualitative heterogeneity between studies was too large to report a meaningful meta-analysis of outcomes using generic inverse variance. This resulted in a meta-analysis, including studies with patients who only have COVID-19.

Intubation

The odds ratio (OR) for intubation was 0.72 (95% CI: 0.43–1.22; P=0.220; I 2=75%) for patients who had awake prone positioning compared with supine controls, showing a non-significant benefit and large heterogeneity (see Fig. 3 ). There was a pooled intubation rate of 38.3% for patients with awake prone positioning amongst 12 studies reporting this information. The subgroup analysis of those placed in the prone position >4 h showed an OR for intubation of 1.15 (0.66–1.99; P=0.630; I 2=70%), whereas those placed in the prone position <4 h had an OR of 0.30 (0.18–0.49; P<0.001; I 2=0%). We observed large differences in heterogeneity between these analyses, so we would advise caution in interpreting these results. A small RCT found no difference within 30-day mortality when comparing patients placed in prone position for a median of 3.4 h vs a median of 9 h (cumulative hours per day).

Fig 3

Secondary outcome: intubation. Forest plot demonstrating pooled data of intubation across studies with comparator group using a random effects model. CI, confidence interval.

Mortality

Mortality of patients placed in the prone position was reported in 11 studies, with a pooled mortality of 16.8%. The OR for mortality was 0.57 (95% CI: 0.36–0.93; P=0.02; I 2=51%), indicating a statistically significant improvement in prone compared with supine patients (see Fig. 4 ). A subgroup analysis of patients placed in the prone position >4 h revealed an OR for mortality of 0.30 (0.10–0.92; P=0.0001; I 2=86%). Only one study reported mortality rate in patients placed in the prone position <4 h, preventing further subgroup analysis. The small RCT reported no difference was seen in patients placed in the prone position for a cumulative median of 3.4 h compared with those placed in the prone position for 9 h (HR 2.29 [0.57; 9.14]; P=0.300).

Fig 4

Secondary outcome: mortality. Forest plot demonstrating pooled data of mortality across studies with comparator group using a random effects model. CI, confidence interval.

ICU admission

Only four studies reported incidence of critical care admission, and this was mainly amongst those with no control group. A study observing a selected cohort of patients undertaking awake prone positioning in the emergency department reported 41% (9/22;) incidence of ICU admission. A retrospective cohort study that compared a prone and supine group observed no difference in critical care admission rate (HR 1.14 [0.96, 1.34]; P=0.183). Higher incidence of ICU admission has been noted in patients placed in the prone position for less than 1 h compared with those placed in the prone position for more than 1 h (APP <1 h: 83%, 10/12 vs APP >1 h: 41%, 14/34; P=0.011). A recent RCT found no difference in rate of ICU admission between patients placed in the prone position for a cumulative median of 3.4 h compared with those placed in the prone position for 9 h (P=0.580).

Time and duration of prone positioning

All studies considered different time of enrolment for APP; therefore, stratification based on S/F ratio or P/F ratio was not possible (see Supplementary files). Similarly, authors used various oxygen delivery interface alongside APP, making a subgroup analysis not feasible.

Amongst the studies, the duration of prone positioning varied from less than 1 h up to 16 h day−1. Median duration of APP was 3 h (IQR: 2–16 h), but was not reported in four studies. Awake proning was not tolerated in 15% of patients across six studies reporting this information.

Respiratory changes during and after prone positioning

Only six studies (42%) reported changes in ventilatory frequency (VF) pre- and post-PP. Data are equally divided, with 50% (three of six studies) reporting a statistically significant reduction in VF, or conversely no significant difference was observed after pronation (refer to Supplementary files).

Adverse events

No significant adverse events were reported, but common limitations were back pain (6%), intolerance (5%), anxiety (3%), discomfort (2%), refusal (2%), pressure sores (2%), hypoxaemia (1%), and accidental lines removal (1%). The small RCT reported two cardiac arrests in patients placed in the prone position for a median of 9 h (2/36), and one cardiac arrest in the control group (1/39) placed in the prone position for a median of 3.4 h, but none were attributable to or associated with awake prone positioning.

Discussion

Our systematic review and meta-analysis pooled results from 12 observational studies from international settings, including 1156 non-intubated patients with ARF caused by ARDS or COVID-19 respiratory failure. The primary meta-analysis revealed significant improvement in Pa/FiO2 ratio and lower mortality, but intubation ratio was unchanged in the prone positioning group.

The specific effects of awake prone positioning in patients with ARF are not yet fully understood. The improvement in oxygenation would suggest that awake prone positioning may follow similar pathophysiological consideration as for intubated patients, irrespective of the nature triggering the underlying lung injury. Several physiological mechanisms may explain the improvement in oxygenation in viral pneumonia (i.e. SARS-CoV-2 or influenza) or ARDS. In prone positioning, the application of a gravitational weight shifts local forces and gradient reopening non-aerated or poorly aerated areas (baby lung concept); therefore, lung recruitment of the posterior dependent lung regions is promoted by reversal of atelectasis. When spontaneously breathing patients are placed in prone positioning, a more homogeneous ventilation is promoted by reduced lung stretch and strain with changes in pleural pressure and pleural space distribution throughout lung regions. , The improvement in ventilation/perfusion (V/Q) matching may be attributable to better distribution of physical forces (i.e. changes in pleural pressure gradients and gravitational forces and distribution of transpulmonary pressure) and reduced the ‘pendelluft phenomenon’ (i.e. the displacement of gas from a more recruited non-dependent lung region to a less recruited dependent lung region). Although lung aeration becomes more homogeneous, shunting can be reduced as the perfusion pattern remains relatively constant. These may be the reasons why this short-term intervention would be beneficial and improve patient-centred outcome, such as mortality. The results of this study are consistent with previous systematic reviews supporting that PP in intubated patients with severe ARDS significantly reduced mortality. ,

The value of awake prone positioning alongside NIV in reducing intubation is questionable, and our results uphold this. Some observational studies have reported decreased VF and excessive work of breathing amongst those awake and placed in the prone position, resulting in a trend towards reduced intubation rate. , , , On the contrary, a prospective observational study found no benefit in reducing the risk of intubation, but rather showed a trend for delay. A decrease in VF in awake prone positioning may be the result of the decrease in respiratory strain, and this is of clinical importance in avoiding tracheal intubation. We would recommend that future studies report VF as a matter of routine.

In non-intubated patients, a short improvement in oxygenation with awake prone positioning without reducing vigorous spontaneous inspiratory efforts may potentially aggravate lung damage, leading to patient self-inflicted lung injury (P-SILI). , P-SILI remains hypothetical, and its clinical implication is yet to be established. This concept has polarised clinicians into different ideological positions, and for some, it is a cause of concern for which advocating for intubation and invasive mechanical ventilation to be ‘performed as soon as possible’ to prevent disease progression. , However, no difference has been found in mortality or duration of mechanical ventilation comparing critically ill patients with COVID-19 respiratory failure who were intubated early with those intubated late. Therefore, P-SILI should not be a justification for performing intubation, and the harm associated with elective early intubation may outweigh the theoretical benefit. Further research should explore the hypothesis if a clear threshold for undertaking intubation and mechanical ventilation exists, and mechanical ventilation should not be the sole solution investigated.

A recent small RCT showed no reduction in intubation or 30-day mortality rate. However, the neutral results may be explained by underpowered analysis, awake prone positioning combined with lateral position, and awake prone positioning largely used in the control group. The true impact of intubation and mechanical ventilation on ARDS and COVID-19 respiratory failure is still not entirely understood, and further research is warranted. We should be cautious about liberal intubation recommendations, and clinical decisions should be patient specific. Use of intubation and mechanical ventilation are associated with severe complications and increased mortality, , and need greater resources, including not only ventilators, but also adequately trained clinicians. In future studies, we recommend reporting the incidence of ventilator-acquired pneumonia and, if numbers permit, analysis by differing oxygen delivery interfaces.

Overall, we found minimal consistency regarding application of awake proning, and there is no clarity about the timing when to start and the optimal duration. Further research is needed to understand when awake prone positioning should be commenced and specifically at what stage (mild vs moderate hypoxia).

Tolerance is a major limitation, and it is not feasible aiming for a similar duration of awake prone positioning (>16 h day−1) as per intubated patients. The effect of prone positioning may be time dependent and stage dependent (mild vs severe respiratory failure), but no difference has been found in intubation or mortality rate comparing awake prone positioning for 3.4 h vs 9 h. Ultimately, protocols should target for awake prone positioning more than 1 h, as less has been found to be associated with higher critical care admission and intubation rate. ,

Awake proning appears safe, and a further advantage is that it allows patients to interact with families during hospitalisation, favouring humanisation of care. Patient compliance is key and may be influenced by common factors, such as back pain, intolerance, and anxiety, which make refusal and non-compliance likely. Additional important limiting factors may be obesity (especially central obesity), pregnancy, and most of all the assistance of dedicated healthcare practitioners that can prevent further injuries to the patient. The management of a conscious but rapidly deteriorating patient can be extremely difficult at the ward level; therefore, awake proning requires close input from doctors, nurses, and physiotherapists to ensure it is successful especially during initial sessions. Patients must be aware of the procedure and be cooperative, and clinicians should be mindful of practical considerations, such as optimisation of analgesia, adequate communication, and assistance to improve comfort, adherence, and proper positioning.

Our review is unique as the first to establish a series of important analyses to reflect contemporary application of prone positioning in non-intubated patients with hypoxaemic respiratory failure. The paucity of evidence available consists of the main limitation of this review, as the majority of the studies included are observational in nature. Our review generates the hypothesis if further high-quality evidence is needed. The initial interest surrounding APP was the expectation that this may be a safe and effective strategy able to optimise ventilator shortage during the surge of the SARS-CoV-2 pandemic. Awake prone position may be a potential beneficial and effective intervention, but it may not be significant until applied in the optimal time and duration and to the right population. Awake prone position is a low-cost strategy and practical tool to manage deteriorating patients, but it should be applied by trained practitioners and intubation should not be delayed when clinically indicated. Our findings highlight the importance of identifying a responsive target population and mastering the specifics of the approach and execution of the intervention. These should be the focus of future studies. Larger and well-designed studies (ideally RCTs) are needed to explore the subject more rigorously.

Conclusions

Awake prone positioning may be a promising therapy for non-intubated patients with hypoxaemic respiratory failure attributable to ARDS or COVID-19. Potential benefits include improvement in oxygenation and mortality rate, but there is no significant effect on incidence of intubation or critical care admission. The optimal frequency, duration, and criteria for starting or stopping proning remain unclear. Although no significant adverse events attributable to awake prone positioning were reported, awake prone positioning is not without limitations, and it is associated with intolerance, discomfort, and anxiety.

Authors' contributions

Study design: BF, RP, ZP

Data collection/analysis: BF, AP

Data interpretation: all authors.

Writing of first draft of the paper: BF, AP

Revising of paper for important intellectual content: all authors.

Approval of final version: all authors.

Declaration of interest

RP is an editor of the British Journal of Anaesthesia. The other authors have no conflicts of interest to declare.